09140

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

October 7, 2013 Cover

Volume 91, Issue 40

Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how

Cover image:

Credit:

Full Article

Volume 91 | Issue 40

« Prev

Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how

ACS Meeting News: Advances in semiconductor and organic light-emitting diodes could lead to more-efficient lighting

Companies from East and West brace for an era of regulatory reform

Business

AstraZeneca’s Experiment

Firm hopes a move to Europe’s largest biotech community, Cambridge, will boost its anemic drug pipeline
Environment

EPA Tries Capping Power Plant Carbon

First-time CO₂ limits proposed for new coal or gas-fired plants
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime